Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / INVVY - FDA pulls Sublocade Orphan Drug status Braeburn's Brixadi to get nod in 2020


INVVY - FDA pulls Sublocade Orphan Drug status Braeburn's Brixadi to get nod in 2020

  • The FDA has granted Braeburn Pharmaceuticals' (BBRX) Citizen Petition seeking a revocation of Orphan Drug status for Indivior PLC's (OTCPK:INVVY) Sublocade (buprenorphine extended-release) injection, approved in the U.S. on November 30, 2017 for the treatment of moderate-to-severe opioid addiction.
  • More news on: Braeburn Pharmaceuticals, Indivior PLC, Indivior PLC, Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Indivior PLC ADR
Stock Symbol: INVVY
Market: OTC
Website: indivior.com

Menu

INVVY INVVY Quote INVVY Short INVVY News INVVY Articles INVVY Message Board
Get INVVY Alerts

News, Short Squeeze, Breakout and More Instantly...